NEW YORK (360Dx) – Cell-based cancer diagnostics firm Celcuity on Wednesday filed with the US Securities and Exchange Commission for an initial public offering of $15 million.

The Minneapolis-based firm has not priced its shares yet or said how many shares it intends to offer. It plans to list its shares on the Nasdaq under ticker symbol "CELC." Craig-Hallum Capital is the underwriter for the offering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.